Biotechnology VALUE FUND L P, 10% Owner, Director at Olema Pharmaceuticals, Inc. (OLMA), bought 1,479,350 shares at $9.39 ($13.9M) on 2021-11-30, disclosed to the SEC on 2021-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.39 | 35,268 | $331K | 2.4% |
| 2 | $9.39 | 35,268 | $331K | 2.4% |
| 3 | $9.39 | 341,977 | $3.2M | 23.1% |
| 4 | $9.39 | 341,977 | $3.2M | 23.1% |
| 5 | $9.39 | 362,430 | $3.4M | 24.5% |
| 6 | $9.39 | 362,430 |
| $3.4M |
| 24.5% |
| Total | $9.39 avg | 1,479,350 | $13.9M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |
| RAIN | BUY | 2021-07-06 | $15.7M | — | Filing → |